60 filings
Page 3 of 3
8-K
t38dsqe j9e45q7emf2g
11 Feb 22
Developing innovative therapeutics and diagnostics to address unmet needs Corporate Presentation / February 2022 www.revbiosciences.com
12:00am
8-K
p8wi4c ncpjp
27 Jan 22
Entry into a Material Definitive Agreement
4:05pm
8-K
tlsb22ay4dwzyyw68
14 Jan 22
Completion of Acquisition or Disposition of Assets
4:28pm
8-K
6veb7r1xz4yva kcigfy
13 Jan 22
Developing innovative therapeutics and diagnostics to address unmet needs Corporate Presentation / January 2022
3:53pm
8-K
sr27r1wp76xi3ekq
12 Jan 22
Amendments to Articles of Incorporation or Bylaws
4:49pm
8-K
fx7uj8 8yzko
23 Dec 21
Petra Acquisition, Inc. Announces Share Redemption Backstop and Forward Purchase Agreements in Revelation Biosciences, Inc. Business Combination
5:27pm
8-K
mqoa7uk3dr923pa
17 Dec 21
Other Events
3:31pm
8-K
7a6wg8jbh plr
24 Nov 21
Other Events
5:17pm
8-K
itenyog8q c3
19 Oct 21
Entry into a Material Definitive Agreement
5:23pm
8-K
g416 m9sr9s6o4iso9s
13 Oct 21
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
51iueh3cjb2 l12dke13
23 Sep 21
Entry into a Material Definitive Agreement
5:22pm
8-K
6zpiwgyo
2 Sep 21
Entry into a Material Definitive Agreement
5:11pm
8-K
m9excz87xfvvsc2j66
31 Aug 21
Regulation FD Disclosure
6:06am
8-K
22bv4j7gwwgk ar
16 Jun 21
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:43pm
8-K
rny5j2qq6w1ttff69
1 Jun 21
Petra Acquisition, Inc. Receives Expected Nasdaq Notification Regarding Delayed Form 10-Q
4:31pm
8-K/A
5gk 2zdm3vw87
5 Mar 21
Departure of Directors or Certain Officers
4:54pm
8-K
jvfv 390tx2hm4
23 Feb 21
Departure of Directors or Certain Officers
4:00pm
8-K
4ev2yskj7
10 Nov 20
Petra Acquisition, Inc. Announces Securities to Commence Separate Trading
4:05pm
8-K
wx9mt5n
19 Oct 20
Index to Financial Statement
5:30pm
8-K
3kdb2h
13 Oct 20
Petra Acquisition Inc. Announces Pricing of $70 Million Initial Public Offering
5:20pm